
Keywords: Biologic therapy; Comorbidities; Adherence; Inhaled corticosteroid; Phenotype; Severe asthma; ABPA; Allergic bronchopulmonary aspergillosis; AERD; Aspirin-exacerbated respiratory disease; COPD; Chronic obstructive pulmonary disease; CRS; Chronic rhinosinu